Flag of the European Union EU Clinical Trials Register Help

Clinical trials for TRACE

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

  • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).


    The EU Clinical Trials Register currently displays   44339   clinical trials with a EudraCT protocol, of which   7369   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    Query did not match any clinical trials.
    These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006).
    Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records.
    1  2  Next»
    Study title: Samoilenko I.G.,Yulish E.I., Gadetskaya S.G., Buchtiarov E.V.: New approach to treat pediatric patients suffering from bronchial asthma associated with intracellular infection. Biological Therapy (Ukraine), 2006, 4: 10-13 [IIT-publication]
    Active substance: Echinacea compositum-Heel - Ampullen
    Study summary document link (including results):
    View full study record
    Document reference: 39861
    Study title: Comparison of emedastine 0.05% or nedocromil sodium 2% eye drops and placebo in controlling local reactions in subjects with allergic conjunctivitis. Orfeo V, Vardaro A, Lena P, Mensitieri I, Tracey M, De Marco R Eur J Ophthalmol. 2002 Jul-Aug;12(4):262-6. Comparison of emedastine 0.05% or nedocromil sodium 2% eye drops and placebo in controlling local reactions in subjects with allergic conjunctivitis. Orfeo V, Vardaro A, Lena P, Mensitieri I, Tracey M, De Marco R Eur J Ophthalmol. 2002 Jul-Aug;12(4):262-6.
    Active substance: emedastine
    Study summary document link (including results):
    View full study record
    Document reference: 41505
    Study title: Eur J Contracep Repro Health Care 2007;12(3):240-7
    Active substance: ETHINYLESTRADIOL_AND_ETONOGESTREL
    Study summary document link (including results):
    View full study record
    Document reference: 26637
    Study title: Observational trial regarding contraceptive efficacy, cycle control and tolerance of Miranova® (levonorgestrel 100 µg + ethinyl estradiol 20 µg) in 13,085 women over 6 treatment cycles
    Active substance: ETHINYLESTRADIOL_AND_LEVONORGESTREL
    Study summary document link (including results):
    View full study record
    Document reference: 26640
    Study title: Arribas Mir L. et al. Indicación de un método anticonceptivo a una adolescente: implante subcutáneo de gestágeno. (Indication of a contraceptive method to a teenager: subcutaneous implant of gestagen). Atención Primaria 2004;34:499-503
    Active substance: ETONOGESTREL
    Study summary document link (including results):
    View full study record
    Document reference: 26667
    Study title: Arzneimittelkommission der deutchen Ärzteschaft. Aus der UAW-Datenbank: Misslungene Explantation des implantierbaren Kontrazeptivums Implanon® (From the AE database: Failed removals of the implantable contraceptive Implanon®). Deutsches Ärzteblatt 2006;25:A1771
    Active substance: ETONOGESTREL
    Study summary document link (including results):
    View full study record
    Document reference: 26669
    Study title: Ahrendt HJ, Karck U, Pichl T, Mueller T, Ernst, U. The effects of an oestrogen-free, desogestrel-containing oral contraceptive in women with cyclical symptoms: Results from two studies on oestrogen-related symptoms and dysmenorrhoea. Eu J Contraception R
    Active substance: DESOGESTREL AND ETHINYLESTRADIOL
    Study summary document link (including results):
    View full study record
    Document reference: 25674
    Study title: Arul GS, Dolan G, Rance CH, Singh SJ, Sommers J. Coeliac axis thrombosis associated with the combined oral contraceptive pill: a rare cause of an acute abdominal . Pediatr. Surg. Int. 1998;13/4:285-7.Arul GS, Dolan G, Rance CH, Singh SJ, Sommers J. Coeliac axis thrombosis associated with the combined oral contraceptive pill: a rare cause of an acute abdominal . Pediatr. Surg. Int. 1998;13/4:285-7.
    Active substance: DESOGESTREL AND ETHINYLESTRADIOL
    Study summary document link (including results):
    View full study record
    Document reference: 25671
    Study title: Pelletier J, Cabanot C, Levrier O, Thuillier JN, Cherif AA. Angiodysplasia of Moya-Moya type disclosed by choreic unvoluntary abnormal movements during oral contraception. Rev Neurol (Paris) 1997;153:393-7.Pelletier J, Cabanot C, Levrier O, Thuillier JN, Cherif AA. Angiodysplasia of Moya-Moya type disclosed by choreic unvoluntary abnormal movements during oral contraception. Rev Neurol (Paris) 1997;153:393-7.
    Active substance: DESOGESTREL AND ETHINYLESTRADIOL
    Study summary document link (including results):
    View full study record
    Document reference: 25675
    Study title: Ahrendt HJ, Karck U, Pichl T, Mueller T, Ernst, U. The effects of an oestrogen-free, desogestrel-containing oral contraceptive in women with cyclical symptoms: Results from two studies on oestrogen-related symptoms and dysmenorrhoea. Eu J Contraception R
    Active substance: DESOGESTREL
    Study summary document link (including results):
    View full study record
    Document reference: 25669
    Study title: Samoilenko I.G.,Yulish E.I., Gadetskaya S.G., Buchtiarov E.V.: New approach to treat pediatric patients suffering from bronchial asthma associated with intracellular infection. Biological Therapy (Ukraine), 2006, 4: 10-13 [IIT-publication]
    Active substance: Mucosa compositum
    Study summary document link (including results):
    View full study record
    Document reference: 40075
    Study title: Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1105-13. Epub 2004 Mar 9. Non-malignant FDG uptake in infradiaphragmatic adipose tissue: a new site of physiological tracer biodistribution characterised by PET/CT. Bar-Shalom R, Gaitini D, Keidar Z, Israel O.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28132
    Study title: Oral contraceptive use and focal nodular hyperplasia of the liver;Mathieu D; Gastroenterology; 2000 vol.118 p.560-564Oral contraceptive use and focal nodular hyperplasia of the liver;Mathieu D; Gastroenterology; 2000 vol.118 p.560-564
    Active substance: GADOTERIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 28855
    Study title: Therapeutic interventions to prevent intracerebral hemorrhage in preterm infants.
    Active substance: INDOMETHACIN
    Study summary document link (including results):
    View full study record
    Document reference: 30043
    Study title: Bar-Shalom R, Gaitini D, Keidar Z, Israel O.. Non-malignant FDG uptake in infradiaphragmatic adipose tissue: a new site of physiological tracer biodistribution characterised by PET/CT. [bar-shalam-2004Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1105-13. Epub 2004 Mar 9. Bar-Shalom R 2004
    Active substance: Steripet
    Study summary document link (including results): 2011-09 GE response Template List of published articles.doc
    View full study record
    Document reference: 48628
    Study title: Clin Nucl Med. 1999 Jun;24(6):435-9. Tc-99m DTPA used as reference imaging to evaluate the distribution of other tumor-seeking tracers in tumors associated with neurofibromatosis. Suga K, Hirabayashi A, Kishimoto K, Kume N, Matsumoto T, Matsunaga N. Clin Nucl Med. 1999 Jun;24(6):435-9. Tc-99m DTPA used as reference imaging to evaluate the distribution of other tumor-seeking tracers in tumors associated with neurofibromatosis. Suga K, Hirabayashi A, Kishimoto K, Kume N, Matsumoto T, Matsunaga N.
    Active substance: THALLIUM 201T1 CHLORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 44556
    Study title: Iodine supplementation: A comparison of oral and intramuscular methods in the improvement of thyroid function and prophylaxis of goitre. ; Malone-F-J. Trace Elements and Electrocytes, 1996, Vol /Iss/Pg. 13/3 (133-135)Iodine supplementation: A comparison of oral and intramuscular methods in the improvement of thyroid function and prophylaxis of goitre. ; Malone-F-J. Trace Elements and Electrocytes, 1996, Vol /Iss/Pg. 13/3 (133-135)
    Active substance: IODINE
    Study summary document link (including results):
    View full study record
    Document reference: 30271
    Study title: Jacobs F, Thierens H, Piepsz A, Bacher K, van de Wiele C, Ham H et al. Optimised tracer-dependent dosage cards to obtain weight-independent effective doses. [jacobs 2005Eur J Nucl Med Mol Imaging 2005; 32 : 581 - 588. Jacobs F 2005
    Active substance: Steripet
    Study summary document link (including results): 2011-09 GE response Template List of published articles.doc
    View full study record
    Document reference: 48662
    Study title: DECREASED TRACER UPTAKE IN BONE TISSUE IN PAEDIATRIC REFLEX SYMPATHETIC DYSTROPHYX. Le Loet, J. Lefort, A. Daragon, B. Derumeaux, P. Deshayes Rheumatology Department, La Prévotière, Hôpital de Bois Guillaume, BP 100, F 76230 Bois Guillaume
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 48845
    Study title: Pickuth D, McCready VR. Focal areas of increased renal tracer uptake on bone scans can mimic metastases in the lower ribs. Br J Radiol. 1996 May;69(821):407-9. Pickuth D, McCready VR. Focal areas of increased renal tracer uptake on bone scans can mimic metastases in the lower ribs. Br J Radiol. 1996 May;69(821):407-9.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 43568
    1  2  Next»
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu May 29 11:05:56 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA